Get started
Author

Eduardo Lasalvia-Galante

Observed names: E Lasalvia-Galante, E. Lasalvia-Galante, E. M. Lasalvia-Galante, E.E. Lasalvia-Galante, Eduardo E. Lasalvia-Galante, Eduardo Lasalvia- Galante, Eduardo Lasalvia-galante
OpenAlex ID: A5042893333
Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients
2004 · Eduardo Lasalvia-Prisco, Silvia Cucchi, et al. · Cancer Chemotherapy and Pharmacology · 24
Addition of an induction regimen of antiangiogenesis and antitumor immunity to standard chemotherapy improves survival in advanced malignancies
2012 · Eduardo Lasalvia-Prisco, Pablo Goldschmidt, et al. · Medical Oncology · 22
PDF
Serum Markers Variation Consistent with Autoschizis Induced by Ascorbic Acid-Menadione in Patients with Prostate Cancer
2003 · Eduardo Lasalvia-Prisco, Silvia Cucchi, et al. · Medical Oncology · 18
Hot infusions and risk of colorectal cancer in Uruguay: a case–control study
2017 · A L Ronco, E De Stefani, et al. · European Journal of Clinical Nutrition · 13
Advanced breast cancer: anti-progressive immunotherapy using a thermostable autologous hemoderivative
2006 · Eduardo Lasalvia-Prisco, Jesús Vázquez, et al. · Breast Cancer Research and Treatment · 13
‘Mate’ Intake, Hormone-Based Risk Factors and Breast Cancer: a Case-Control Study
2017 · Alvaro L Ronco, Edison Espinosa, et al. · Europe PMC (PubMed Central) · 9
Antitumoral Effect of a Vaccination Procedure with an Autologous Hemoderivative
2003 · Eduardo Lasalvia-Prisco, Silvia Cucchi, et al. · Cancer Biology & Therapy · 7
PDF
Advanced Colon Cancer: Antiprogressive Immunotherapy Using an Autologous Hemoderivative
2006 · Eduardo Lasalvia-Prisco, Emilio Garcia-Giralt, et al. · Medical Oncology · 5
Ovarian cancer: Autologous immunotherapy optimized by remote adjuvancy of a silicate-induced granuloma
2006 · E. Garcia-Giralt, E. Lasalvia-Prisco, et al. · Journal of Clinical Oncology · 2
Breast cancer: Role of tumor associated antigens and regulatory cells [CD4+CD25+] as targets of the Immune response elicited by an anti-progressive autologous hemoderivative vaccine
2005 · E. Garcia-Giralt, E. Lasalvia-Prisco, et al. · Journal of Clinical Oncology · 1
Immunotherapy enhanced by geroprotection: Hormone-resistant prostate cancer
2017 · E.M. Lasalvia-Prisco, C. Dau, et al. · Annals of Oncology
PDF
Advanced Pancreatic Cancer: Adjuvant Anti-Tolerogenic Immunomodulation Improves Chemoimmunotherapy
2014 · E.M. Lasalvia-Prisco, P. Goldschmidt, et al. · Annals of Oncology
Autologous heterotopic transplant of peripheral blood associated to chemotherapy as immunotherapy of solid tumors.
2012 · Eduardo M. Lasalvia-Prisco, Pablo Goldschmidt, et al. · Journal of Clinical Oncology
Erythrocytes as autologous-vaccine carriers in advanced prostate cancer
2008 · E. M. Lasalvia-Prisco, E. Garcia-Giralt, et al. · Journal of Clinical Oncology
Erythrocytes as autologous-vaccine carriers targeted in breast cancer sentinel lymph node
2008 · E. Garcia-Giralt, E. M. Lasalvia-Prisco, et al. · Journal of Clinical Oncology
Colorectal cancer: Autologous immunogenicity in chemotherapy (5FU) pre-treated patients
2004 · E. Lasalvia-Prisco, S. Cucchi, et al. · Journal of Clinical Oncology
Works count: 17
Citation count: 114
H-index: 7
I10-index: 5
Year
Topic
Type